HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2

Ariella B. Hanker, Joan T. Garrett, Monica Valeria Estrada, Preston D. Moore, Paula Gonzalez Ericsson, James P. Koch, Emma Langley, Sharat Singh, Phillip S. Kim, Garrett M. Frampton, Eric Sanford, Philip Owens, Jennifer Becker, M. Reid Groseclose, Stephen Castellino, Heikki Joensuu, Jens Huober, Jan C. Brase, Samira Majjaj, Sylvain BroheeDavid Venet, David Brown, Jose Baselga, Martine Piccart, Christos Sotiriou, Carlos L. Arteaga

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2'. Together they form a unique fingerprint.

Medicine & Life Sciences